| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2803374 | Growth Hormone & IGF Research | 2007 | 8 Pages |
Abstract
The data show that a short-term administration of GH in the terminal phase of the disease confers cardioprotection by attenuating systolic dysfunction and by inducing beneficial reverse remodeling.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Mukandila Mulumba, Catia Céméus, Louis Dumont, Patrick du Souich, Huy Ong, Sylvie Marleau,